Furthermore, the therapeutic potential of miR-206 in settings of hyperglycaemia has been reported, elucidating mechanistic roles in the inhibition of glucose production and lipogenesis and promotion of insulin signalling28. The gene discussed is INS; the disease is Hyperglycemia.